Head-to-head comparisons of medication uses, side effects, warnings, and more.
Tecentriq (atezolizumab)
Tecentriq hybreza
Tecentriq (atezolizumab)
Tecentriq hybreza
Summary of Tecentriq vs. Tecentriq Hybreza
Summary for PD-L1 inhibitor
Prescription only
Tecentriq (atezolizumab) is an immunotherapy medication that’s used to treat several different types of cancer, like lung cancer, liver cancer, and melanoma. It turns on your immune system to fight cancer. But this can sometimes cause side effects like rash, diarrhea, and lung problems that might need temporary treatment with corticosteroids. Tecentriq (atezolizumab) is given through the vein (intravenously, IV) at an infusion center or provider’s office.
Summary for PD-L1 inhibitor
Prescription only
Tecentriq Hybreza (atezolizumab / hyaluronidase) is an immunotherapy cancer medication that’s given as an injection under the skin. It’s FDA approved for some adults with lung cancer, liver cancer, or melanoma. It can also help treat people 12 years and older with alveolar soft part sarcoma (ASPS). A nurse will give the injection into the thigh every 3 weeks at a clinic. Side effects include tiredness, muscle or bone pain, and cough. Depending on your cancer type and treatment plan, you might take Tecentriq Hybreza on its own or with other chemotherapy.